Richardcyoung.com

The Online Home of Author and Investor, Dick Young

  • Home
  • Debbie Young
  • Jimmy Buffett
  • Key West
  • Your Survival Guy
  • How We Are Different
  • Paris
  • About Us
    • Foundation Principles
    • Contributors
  • Investing
    • You’ve Read The Last Issue of Intelligence Report, Now What?
  • The Great Reset
  • The Swiss Way
  • My Rifles
  • Dividends and Compounding
  • Your Security
  • Dick Young
  • Dick’s R&B Top 100
  • Liberty & Freedom Map
  • Bank Credit & Money
  • Your Survival Guy’s Super States
  • NNT & Cholesterol
  • Your Health
  • Ron Paul
  • US Treasury Yield Curve: My Favorite Investor Tool
  • Anti-Gun Control
  • Anti-Digital Currency
  • Joel Salatin and Alfie Oakes
  • World Gold Mine Production
  • Fidelity and Vanguard Since 1971

Can Curcumin Help in Fighting Cancer?

February 13, 2023 By Richard C. Young

By pinkomelet @ Shutterstock.co

UPDATE 2.13.23: There is new evidence that a combination of curcumin and QingDai may reduce the severity of ulcerative colitis, even including remission. Medical News Today reports:

Ulcerative colitis is a chronic condition that damages the lower digestive tract and can cause many unpleasant symptoms.

People with ulcerative colitis can work with doctors and specialists to manage the disease and maintain remission. Researchers are still working to determine the best treatment options and what medications may help control the disorder.

Two recent studies have explored the use of an herbal combination of curcumin and QingDai to help induce remission in people with ulcerative colitis. Researchers shared the results at the Crohn’s and Colitis Congress 2023.

UPDATE 8.5.22: Scientists in India have found possible pain relief effects of using a compound of curcumin and boswellia to treat pain patients. Natural Products Insider reports:

A multi-center randomized controlled trial (RCT) conducted in India and published online in Scholars Journal of Applied Medicine compared a combination of curcumin and boswellia (Boswellia serrata) to placebo in 232 healthy adults with acute musculoskeletal pain (Scholars J App Med. Online ahead of print, March 20, 2022).

Researchers categorized subjects according to the location of their pain (neck, head, lower limb, etc.), and gave them a single dose of 1,000 mg Rhuleave-K (from Arjuna Natural), or a comparable placebo softgel.

Ruleave-K contains extracts of turmeric (Curcuma longa, 26.6% curcuminoids) and boswellia (1% acetyl keto-boswellic acid) in black sesame seed oil; it features the company’s SPEED technology, designed for rapid dispersal of the active botanical compounds for fast action.

Researchers assessed perceptible pain relief (PPR) and meaningful pain relief (MPR) using a double stopwatch method. They found the PPR and MPR at head, neck, upper limb, trunk, lower limb and the general body were all significantly faster, to varying degrees, in the supplement group.

“The pain relief started as early as 40 minutes and complete pain relief was achieved as early as 160 minutes,” they wrote, concluding the botanical combination was a safe alternative to analgesics commonly prescribed for such pain. “In the five major locations of pain, the [supplement] group had above 96% reduction in pain intensity in all the modalities of rest, movement and pressure whereas the placebo group showed negligent change.”

Originally posted May 10, 2018.

In an article titled “Turmeric Extract Strikes To The Root Cause of Cancer Malignancy,” by Sayer Ji at GreenMed Info, Ji notes a new study that “identifies a number of ways in which curcumin provides an ideal CSC-targeting therapy.” He writes:

A turmeric study published in Cancer Letters is paving the way for a revolution in the way that we both understand and treat cancer.

Whereas conventional models of cancer assumed that the majority of the cancer cells within a tumor possess self-renewal capacity to differing degrees, the CSC model proposes that, “[T]he initiation, maintenance, and growth of a tumor is driven by a minor population of cancer cells termed cancer stem cells (CSCs).

Although it was possible to debulk a tumor with surgery, chemotherapy and radiation, CSC populations were often missed or even enriched as a result. When the tumor mass regrew it often became more invasive and treatment-resistant, resulting in the rapid demise and death of the patient — deaths which are often written off inaccurately or disingenuously as non-treatment related.

Given that conventional treatment can drive an intrinsically benign tumor (i.e., so-called indolent tumors) into greater invasiveness through increasing the number of intrinsically resilient cancer stem cells at the very same moment that it kills the less or non-harmful daughter cells, alternative treatment approaches are needed now more than ever.

Turmeric and curcumin extract have been extensively studied for their ability to kill various cancer cell lines. In fact, the literature is so abundant (see: 600 health benefits of turmeric) that it is both surprising and disheartening that so many patients who are in need of safe, effective and affordable treatments are not being given information about it.

The new study identifies a number of ways in which curcumin provides an ideal CSC-targeting therapy,

©January 29th 2014 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here https://www.greenmedinfo.com/greenmed/newsletter.

If you’re willing to fight for Main Street America, click here to sign up for my free weekly email.

Related Posts

  • Can Your Own Body Cure Cancer with Doctors' Help?
  • CT Scan Cancer Risk
  • Critical Knowledge on the Cancer Front
  • Author
  • Recent Posts
Richard C. Young
Richard C. Young
Richard C. Young is the editor of Young's World Money Forecast, and a contributing editor to both Richardcyoung.com and Youngresearch.com.
Richard C. Young
Latest posts by Richard C. Young (see all)
  • Hong Kong Loses Top Spot in Economic Freedom Index - September 21, 2023
  • Can This Mushroom Boost Your Memory? - September 21, 2023
  • Where Are the Fiscal Conservatives? - September 21, 2023

Dick Young’s Must Reads

  • Concentrate on Dividend Record and Compounding
  • What’s John Kerry Doing in Mexico?
  • BEYOND RUSSIA: America Strengthens India Ties to Counter China
  • Ron Paul: “Freedom and Central Banking Are Not Compatible”
  • Key West’s Best Burger
  • My Battle-Hardened Stock Market Strategy for the Worst of Times
  • YOU DESERVE FREEDOM: Your Hard Work Will Make It Happen
  • Work to Make Money/Invest to Save Money
  • You May Be Surprised by America’s “Least Woke City”
  • Your Sheriff Can Thwart Federal Gun Control Efforts

Our Most Popular Posts

  • A High-Speed Collision with Reality
  • New York Finds a New Way to Harass Gun Owners
  • Will the UAW Get What It Wants?
  • Americans Are Not Happy with Bidenomics
  • Ron Paul Exposed the Fed and the Neocon Scam
  • Don't Tread on America's Children
  • Bidenomics Gutting Real Household Income
  • “I Want to Be a Farmer, a Garbageman, or Tom Brady”
  • Do You Really Need 8 Glasses of Water a Day?
  • So Much for Mozart

Compensation was paid to utilize rankings. Click here to read full disclosure.

RSS Youngresearch.com

  • Will the Fed Hold Up Its End of the Bargain?
  • Should America Move Closer to the Saudis, or Push them Away?
  • Don’t Ask Me When to Haul Your Boat
  • Robot Warehouses Need Better Internet
  • California Mandates Drive Diesel Truck Buying Spree
  • Americans Are Not Happy with Bidenomics
  • Paris’s Big Plans for the Champs-Elysées
  • A Plan for Cutting Federal Government Spending
  • Investing Mistakes to Avoid: #1 Y-O-U
  • Mr. Protect and Preserve: For Where We’re Going

RSS Yoursurvivalguy.com

  • Will the Fed Hold Up Its End of the Bargain?
  • Are Most NFTs Now Worthless?
  • 2ND AMENDMENT ALERT: Biden to Create New Anti-Gun Office
  • Don’t Ask Me When to Haul Your Boat
  • You May Be Surprised by America’s “Least Woke City”
  • GREENWASHING: What’s in a Name?
  • Americans Are Not Happy with Bidenomics
  • “Oh, That Wasn’t So Bad”
  • Prepared for When the Next Black Swan Swoops In?
  • Investing Mistakes to Avoid: #1 Y-O-U

US Treasury Yield Curve: My Favorite Investor Tool

Five Year Treasury Yield

Doctor Faust and the Devil Come Looking

Will the Fed Hold Up Its End of the Bargain?

Hong Kong Loses Top Spot in Economic Freedom Index

Can This Mushroom Boost Your Memory?

Copyright © 2023 | Terms & Conditions | About Us | Dick Young | Archives